0001209191-19-007428.txt : 20190205 0001209191-19-007428.hdr.sgml : 20190205 20190205173047 ACCESSION NUMBER: 0001209191-19-007428 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181001 FILED AS OF DATE: 20190205 DATE AS OF CHANGE: 20190205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maharaj Gary R CENTRAL INDEX KEY: 0001508798 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23837 FILM NUMBER: 19569026 MAIL ADDRESS: STREET 1: 9924 WEST 74TH STREET CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SURMODICS INC CENTRAL INDEX KEY: 0000924717 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411356149 STATE OF INCORPORATION: MN FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 9924 W 74TH ST CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 BUSINESS PHONE: 9525007000 MAIL ADDRESS: STREET 1: 9924 WEST 74TH ST CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 FORMER COMPANY: FORMER CONFORMED NAME: BSI CORP DATE OF NAME CHANGE: 19970506 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-01 0 0000924717 SURMODICS INC SRDX 0001508798 Maharaj Gary R 9924 WEST 74TH STREET EDEN PRAIRIE MN 55344 1 1 0 0 President & CEO Common Stock 2018-10-01 4 S 0 4100 72.0366 D 170767 D Common Stock 2018-10-01 4 S 0 200 72.75 D 170567 D Common Stock 2018-10-01 4 S 0 700 74.1043 D 169867 D Common Stock 2019-02-01 4 S 0 668 51.8681 D 169199 D Common Stock 2019-02-01 4 S 0 925 53.0502 D 168274 D Common Stock 2019-02-01 4 S 0 840 54.049 D 167434 D Common Stock 2019-02-01 4 S 0 300 55.53 D 167134 D Common Stock 2019-02-01 4 S 0 100 56.36 D 167034 D Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018. Reflects the weighted average price of 4,100 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2018 with sale prices ranging from $71.38 to $72.35 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Reflects the weighted average price of 200 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2018 with sale prices ranging from $72.56 to $72.94 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Reflects the weighted average price of 700 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2018 with sale prices ranging from $74.00 to $74.29 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Reflects the weighted average price of 668 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $51.561 to $52.20 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Reflects the weighted average price of 925 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $52.75 to $53.675 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Reflects the weighted average price of 840 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $53.805 to $54.33 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Reflects the weighted average price of 300 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $54.885 to $55.865 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Bryan K. Phillips on behalf of Gary R. Maharaj 2019-02-05